The shares of one of the chemical stock, specializes in the production of specialty chemicals and advanced materials, serving industries such as pharmaceuticals, agrochemicals, electronics, and energy, jumps up to 7.7 percent upon declaring Q3 results and generating profit with 148 percent rise Year on Year (YoY)
Price action
With a market capitalization of Rs. 11,819 crores on Friday, the shares of Aether Industries Limited is up by 7.7 percent making a high of Rs. 920 per share compared to its previous closing price of Rs. 854.25 per share.
What Happened
Aether Industries Limited specializes in the production of specialty chemicals and advanced materials, serving industries such as pharmaceuticals, agrochemicals, electronics, and energy, has announced their Q3FY25 results.
Its revenue from operations grew by 41.4 percent YoY from Rs. 155.36 Crores in Q3FY24 to Rs. 219.68 Crores in Q3FY25 and it grew by 10.5 percent QoQ from Rs. 198.80 Crores in Q2FY25 to Rs. 219.68 Crores in Q3FY25.
Its Net Profit rose by 148.9 percent YoY from Rs. 17.43 Crores in Q3FY24 to Rs. 43.39 Crores in Q3FY25 and it rose by 24.6 percent QoQ from Rs. 34.8 Crores in Q2FY25 to Rs. 43.39 Crores in Q3FY25.
The earnings per share (EPS) for the quarter stood at Rs. 3.27, compared to Rs. 2.63 in the previous quarter and Rs. 1.32 in the same quarter last year.
Revenue by Business Model
Large Scale Manufacturing segment revenue rose by 9.8 percent YoY from Rs. 99.1 Crores in Q3FY24 to Rs. 108.9 Crores in Q3FY25 and it declined by 2.9 percent QoQ from Rs. 112.0 Crores in Q2FY25 to Rs. 108.7 Crores in Q3FY25.
Contract Manufacturing segment revenue rose by 145 percent YoY from Rs. 34.0 Crores in Q3FY24 to Rs. 83.3 Crores in Q3FY25 and it rose by 48.5 percent QoQ from Rs. 56.1 Crores in Q2FY25 to Rs. 83.3 Crores in Q3FY25.
Contract Research and Manufacturing Services (CRAMS) segment revenue rose by 19.8 percent YoY from Rs.20.9 Crores in Q3FY24 to Rs. 25.1 Crores in Q3FY25 and it declined by 9.05 percent QoQ from Rs. 27.6 Crores in Q2FY25 to Rs. 25.1 Crores in Q3FY25.
Other segment revenue rose by 94.5 percent YoY from Rs.1.3 Crores in Q3FY24 to Rs. 2.6 Crores in Q3FY25 and it declined by 16.12 percent QoQ from Rs. 3.1 Crores in Q2FY25 to Rs. 2.6 Crores in Q3FY25.
Aether’s Business Segments
In Q3 FY25, Aether Industries’ revenue was mainly driven by the Pharma segment (47.5 percent) and Agro (11.2 percent). Other key segments included Material Science (9.8 percent), Multiple (12.2 percent), and Coatings (4.1 percent). Oil & Gas contributed (4.3 percent), High Performance Photography (7.6 percent), Food Additives (2.2 percent), and Sustainability & Renewables (1.0 percent)
Written by Sridhar J
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
